Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Six Membered Carbocyclic Purine Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108912123B enables high-purity chiral nucleosides through asymmetric catalysis with simplified process and reduced manufacturing costs.